Emergency department contribution to HCV elimination in the Iberian Peninsula

• Published in: International journal of emergency medicine Vol. 17; no. 1; pp. 5 - 6
• Main Authors: Buti, Maria, Vaz-Pinto, Inês, Magno Pereira, Vítor, Casado, Marta, Llaneras, Jordi, Barreira, Ana, Esteves, Catarina, Guimarães, Mafalda, Gorgulho, Ana, Mourão, Tomás, Xavier, Elisa, Jasmins, Luís, Reis, Ana Paula, Faria, Nancy, Freitas, Bruno, Andrade, Graça, Camelo-Castillo, Anny, Rodríguez-Maresca, Manuel Ángel, Carrodeguas, Alba, Medina, Diogo, Esteban, Rafael
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 04-01-2024; Springer Nature B.V; BMC
• Subjects: Angiology; Cardiology; Diagnosis; Disease control; Emergency department; Emergency medical care; Emergency Medicine; HCV; Health surveillance; Hepatitis C; Internal Medicine; Medical screening; Medicine; Medicine & Public Health; Pediatrics; Screening; Urban health care; Screening; HCV; Emergency department; Diagnosis
• ISSN: 1865-1380; 1865-1380
• DOI: 10.1186/s12245-023-00570-5

Background
Undiagnosed cases of hepatitis C virus (HCV) infection result in significant morbidity and mortality, further transmission, and increased public health costs. Testing in emergency departments (EDs) is an opportunity to expand HCV screening. The goal of this project was to increase the proportion of eligible patients screened for HCV in urban areas.
Methods
An opportunistic automated HCV screening program was implemented in the EDs of 4 public hospitals in Spain and Portugal at different periods between 2018 and 2023. HCV prevalence was prospectively evaluated, and single-step or reflex testing was used for confirmation in the same sample.
Results
More than 90% of the population eligible for testing were screened in the participating centers. We found HCV antibody seroprevalence rates ranging from 0.6 to 3.9%, with between 19 and 53% of viremic individuals.
Conclusions
Opportunistic HCV screening in EDs is feasible, does not disrupt ED activities, is highly effective in increasing diagnosis, and contributes to WHO’s HCV elimination goals.